NCT05017662 2025-09-04A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072Ariceum Therapeutics GmbHPhase NA Completed20 enrolled
NCT03112694 2020-06-02Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine TumorsIpsenCompleted93 enrolled